Organic growth of 12.5% year-over-year in Broadcast and Recurring Commercial Music Revenues;Revenues increased 7.4% to $95.6 million in the first quarter of 2026 from $89.1 million in the first quarter of 2025;Adjusted EBITDA(1) rose 8.3% to $33.7 million in the first quarter of 2026 from $31.1 million in the same period in 2025. Adjusted EBITDA(1) by segment was $24.4 million or 39.8% of revenues for Broadcasting and Commercial Music, $11.0 million or 32.3% of revenues for Radio, and $(1.8) million for Cor ...

公司事件 - Sarepta Therapeutics是一家专注于开发杜氏肌营养不良症治疗方法的商业阶段生物制药公司 其基因治疗产品ELEVIDYS针对特定杜氏肌营养不良症患者群体 [3] - 公司被指控在2023年6月22日至2025年6月24日期间做出虚假或误导性陈述 未披露ELEVIDYS存在重大安全风险 临床试验方案不足以检测严重副作用等关键信息 [3] - 2025年3月18日披露首例ELEVIDYS治疗患者因急性肝衰竭死亡 导致股价下跌超过27% [4] - 2025年4月4日因欧洲监管机构要求审查事件 公司暂停部分ELEVIDYS临床试验的患者招募和给药 股价再跌7% [5] - 2025年6月15日报告第二例ELEVIDYS治疗患者死亡 公司暂停非卧床患者用药并重新评估ENVISION研究方案 股价暴跌42% [6] - 2025年6月24日FDA发布安全通告确认收到两例死亡报告并展开调查 公司股价进一步下跌8% [7] 产品情况 - ELEVIDYS基因疗法存在严重安全风险 两例患者死亡均与急性肝衰竭相关 [4][6] - 产品安全问题导致临床试验暂停 监管审查加强 可能影响现有及未来批准 [3][5][6] - 安全事件引发连锁反应 包括暂停患者招募 给药和产品运输等运营活动 [5][6]

DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role, who has decided to pursue other career opportunities. Krumme will report to Chief Financial Officer, Jill McConnell, and lead Fortrea’s global investor relations strategy, serving as a key liaison to the investment community. “Tracy is a seasoned executi ...

Ever volatile Snap shares fell 17% after market close as second quarter revenue growth was slower than it has been due in part to a mistake that made it cheaper than intended for advertisers to clear at auction. The company said its SVP of Engineering Eric Young is departing to pursue a new opportunity. “Unfortunately, in our efforts to improve advertiser performance, we shipped a change that caused some campaigns to clear the auction at substantially reduced prices,” said Snap’s earnings release. “We have ...

I wrote a bearish article on Apple Inc. (NASDAQ: AAPL ) in May 2025, and at the time the stock was trading for about $208 per share. It's barely down from that level, and I am stillLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest trading ideas: @Hawkinvest1Analyst’s Disclosure:I/we have a beneficia ...

公司财务表现 - 公司公布2025年第二季度非GAAP每股收益为0.57美元 低于市场共识预期0.16美元 [3] - 公司CEO承认财务表现"未达预期" 归因于"某些时间安排和运营问题" [3] 股价变动 - 公司股价在财报发布后单日下跌16.77美元 跌幅达23.63% 收盘价为54.19美元 [3] 法律调查 - 律师事务所已对公司可能存在的证券欺诈行为展开调查 考虑代表投资者提起集体诉讼 [1] - 律师事务所为投资者提供免费案件评估 讨论追偿损失的法律途径 [2] 律所背景 - 该律所在代表投资者追偿公司不当行为造成的损失方面有经验 已为投资者追回超过55亿美元 [4]

TOKYO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CTW Cayman (“CTW” or “the Company”), a leading game platform company providing global access to web-based games through its flagship HTML5 platform, G123.jp, which showcases a diverse selection of free-to-play games inspired by popular Japanese animations, today announced the pricing of the initial public offering (the “Offering”) of 2,400,000 Class A ordinary shares at a public offering price of $5.00 per share. The ordinary shares have been approved for listing on ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Praxis Precision Medicines, Inc. (“Praxis” or “the Company”) (NASDAQ: PRAX) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Praxis investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to cont ...

公司高管任命 - ReGen III Corp宣布任命Brad Kotush为首席财务官，其拥有17年上市公司CFO经验，专长包括资本市场、企业扩张、并购及公开报告[1] - Brad Kotush在Home Capital Group Inc任职期间推动股价上涨约3.4倍，市值增长6亿美元，并通过股息和股票回购向股东返还超15亿美元[2] - 在Canaccord Genuity Group Inc任职期间主导完成超7.5亿美元国内外收购，并将公司业务从2个国家扩展至10个国家[3] 高管背景与能力 - Brad Kotush具备加拿大、英国等多地区财务管理经验，涵盖财务报告、预算、风险管理、投资者关系等领域，持有CPA CA和ICD.D资格认证[4] - CEO Tony Weatherill评价其具备机构知识、全球资本市场专业能力及企业战略扩张的成功记录[5] - Brad Kotush表示将运用其在资本市场和并购经验推动公司下一阶段增长[6] 股权激励与人事变动 - 公司授予Brad Kotush 100万份股票期权，行权价每股0.19美元，有效期5年，分4年归属[6][8] - 原CFO Rick Low于2025年8月5日卸任，将留任顾问6个月以协助交接[11] - 首席战略官Mark Redcliffe转为顾问，其在专利开发、原料协议和融资方面贡献突出[12][13] 公司业务与技术 - ReGen III采用专利技术将废机油转化为高端III类基础油，相比原油衍生品可减少82%生命周期碳排放[13] - 德克萨斯州旗舰工厂设计产能5,600桶/日，已完成FEL2阶段工程，正评估其他战略市场技术部署机会[14] - 公司目标是成为全球最大可持续III类基础油生产商，推动润滑油市场向循环经济转型[15]

Investors can contact the law firm at no cost to learn more about recovering their losses​ LOS ANGELES, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Insperity, Inc. (“Insperity” or “the Company”) (NYSE: NSP) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Insperity investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney ...